Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How to randomize.

Andrew J Vickers1

  • 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. vickersa@mskcc.org

Journal of the Society for Integrative Oncology
|October 7, 2006
PubMed
Summary
This summary is machine-generated.

Proper randomization in clinical trials is crucial for preventing bias in integrative oncology research. Secure methods like password-protected databases ensure patient allocation integrity and group balance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.

European urology·2024
Same author

Successful completion of large, low-cost randomized cancer trials at an academic cancer center.

Clinical trials (London, England)·2024
Same author

Testosterone Therapy in Men After Radical Prostatectomy for Low-Intermediate Organ-Confined Prostate Cancer.

The Journal of urology·2024
Same author

Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk.

European urology·2024
Same author

Transperineal vs Transrectal Prostate Biopsy-The PREVENT Randomized Clinical Trial.

JAMA oncology·2024
Same author

Clinical utility of an artificial intelligence radiomics-based tool for risk stratification of pulmonary nodules.

JNCI cancer spectrum·2024

Area of Science:

  • Clinical Trials Methodology
  • Integrative Oncology Research
  • Biostatistics

Background:

  • Randomized trials are essential for evaluating the efficacy and safety of integrative oncology therapies.
  • Inadequate attention to randomization procedures is common, compromising study validity.
  • Existing methods like telephone randomization and opaque envelopes are vulnerable to subversion.

Purpose of the Study:

  • To highlight the critical importance of robust randomization in clinical trials.
  • To identify potential flaws in common randomization techniques.
  • To recommend secure randomization methods for ensuring unbiased trial outcomes.

Main Methods:

  • Discussion of selection bias and its prevention through proper randomization.
  • Evaluation of common randomization methods, including telephone and opaque envelopes.

Related Experiment Videos

  • Proposal of secure randomization systems, such as pharmaceutical company-managed blinded medication or secure database systems.

    • Main Results:

    • Many studies report inadequate randomization procedures, potentially introducing bias.
    • Telephone randomization and opaque envelopes can be subverted, undermining allocation concealment.
    • Secure randomization methods are necessary to prevent prediction and alteration of patient group assignment.

    Conclusions:

    • Integrative oncology research relies on rigorous randomization to establish treatment efficacy and safety.
    • Secure, computer-based randomization systems (e.g., password-protected databases) are recommended.
    • These systems facilitate advanced techniques like blocking, stratification, and minimization for optimal group balance.